换一批
换一批Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.
作者：
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);抗体, 单克隆(Antibodies, Monoclonal);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);剂量效应关系, 药物(Dose-Response Relationship, Drug);多柔比星(Doxorubicin);用药计划表(Drug Administration Schedule);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);女(雌)性(Female);基因, myc(Genes, myc);人类(Humans);原位杂交, 荧光(In Situ Hybridization, Fluorescence);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);试验预期值(Predictive Value of Tests);泼尼松(Prednisone);概率(Probability);预后(Prognosis);比例危险度模型(Proportional Hazards Models);原癌基因蛋白质c-bcl-2(Proto-Oncogene Proteins c-bcl-2);危险性评估(Risk Assessment);疾病严重程度指数(Severity of Illness Index);存活率分析(Survival Analysis);治疗结果(Treatment Outcome);长春新碱(Vincristine)
DOI
10.1200/JCO.2009.22.7058
PMID
19786664
发布时间
2015-11-19
- 浏览22
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
